BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31471462)

  • 1. NLRP3 gain-of-function in CD4
    Braga TT; Brandao WN; Azevedo H; Terra FF; Melo ACL; Pereira FV; Andrade-Oliveira V; Hiyane MI; Peron JPS; Camara NOS
    Clin Sci (Lond); 2019 Sep; 133(17):1901-1916. PubMed ID: 31471462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses.
    Gris D; Ye Z; Iocca HA; Wen H; Craven RR; Gris P; Huang M; Schneider M; Miller SD; Ting JP
    J Immunol; 2010 Jul; 185(2):974-81. PubMed ID: 20574004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eomesodermin Expression in CD4+ T Cells Restricts Peripheral Foxp3 Induction.
    Lupar E; Brack M; Garnier L; Laffont S; Rauch KS; Schachtrup K; Arnold SJ; Guéry JC; Izcue A
    J Immunol; 2015 Nov; 195(10):4742-52. PubMed ID: 26453746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The central nervous system environment controls effector CD4+ T cell cytokine profile in experimental allergic encephalomyelitis.
    Krakowski ML; Owens T
    Eur J Immunol; 1997 Nov; 27(11):2840-7. PubMed ID: 9394808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoreactive Tbet-positive CD4 T cells develop independent of classic Th1 cytokine signaling during experimental autoimmune encephalomyelitis.
    Yeh WI; McWilliams IL; Harrington LE
    J Immunol; 2011 Nov; 187(10):4998-5006. PubMed ID: 21984703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell-intrinsic ASC critically promotes T(H)17-mediated experimental autoimmune encephalomyelitis.
    Martin BN; Wang C; Zhang CJ; Kang Z; Gulen MF; Zepp JA; Zhao J; Bian G; Do JS; Min B; Pavicic PG; El-Sanadi C; Fox PL; Akitsu A; Iwakura Y; Sarkar A; Wewers MD; Kaiser WJ; Mocarski ES; Rothenberg ME; Hise AG; Dubyak GR; Ransohoff RM; Li X
    Nat Immunol; 2016 May; 17(5):583-92. PubMed ID: 26998763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity.
    Lalor SJ; Dungan LS; Sutton CE; Basdeo SA; Fletcher JM; Mills KH
    J Immunol; 2011 May; 186(10):5738-48. PubMed ID: 21471445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
    Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
    Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gp130-dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation.
    Haroon F; Drögemüller K; Händel U; Brunn A; Reinhold D; Nishanth G; Mueller W; Trautwein C; Ernst M; Deckert M; Schlüter D
    J Immunol; 2011 Jun; 186(11):6521-31. PubMed ID: 21515788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC; Lalor SJ; Lynch MA; Mills KH
    Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
    de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
    Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-associated changes in rat immune system: lessons learned from experimental autoimmune encephalomyelitis.
    Djikić J; Nacka-Aleksić M; Pilipović I; Stojić-Vukanić Z; Bufan B; Kosec D; Dimitrijević M; Leposavić G
    Exp Gerontol; 2014 Oct; 58():179-97. PubMed ID: 25128713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective ORAI1 Inhibition Ameliorates Autoimmune Central Nervous System Inflammation by Suppressing Effector but Not Regulatory T Cell Function.
    Kaufmann U; Shaw PJ; Kozhaya L; Subramanian R; Gaida K; Unutmaz D; McBride HJ; Feske S
    J Immunol; 2016 Jan; 196(2):573-85. PubMed ID: 26673135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase C θ regulates the phenotype of murine CD4+ Th17 cells.
    Wachowicz K; Hermann-Kleiter N; Meisel M; Siegmund K; Thuille N; Baier G
    PLoS One; 2014; 9(5):e96401. PubMed ID: 24788550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
    Mony JT; Khorooshi R; Owens T
    Mult Scler; 2014 Sep; 20(10):1312-21. PubMed ID: 24552747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of IL-12 receptor beta 1 in regulation of T cell response by APC in experimental autoimmune encephalomyelitis.
    Zhang GX; Yu S; Gran B; Li J; Siglienti I; Chen X; Calida D; Ventura E; Kamoun M; Rostami A
    J Immunol; 2003 Nov; 171(9):4485-92. PubMed ID: 14568921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invariant NKT cells producing IL-4 or IL-10, but not IFN-gamma, inhibit the Th1 response in experimental autoimmune encephalomyelitis, whereas none of these cells inhibits the Th17 response.
    Oh SJ; Chung DH
    J Immunol; 2011 Jun; 186(12):6815-21. PubMed ID: 21572032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance.
    Álvarez-Sánchez N; Cruz-Chamorro I; López-González A; Utrilla JC; Fernández-Santos JM; Martínez-López A; Lardone PJ; Guerrero JM; Carrillo-Vico A
    Brain Behav Immun; 2015 Nov; 50():101-114. PubMed ID: 26130320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lineage-Specific Metabolic Properties and Vulnerabilities of T Cells in the Demyelinating Central Nervous System.
    Seki SM; Stevenson M; Rosen AM; Arandjelovic S; Gemta L; Bullock TNJ; Gaultier A
    J Immunol; 2017 Jun; 198(12):4607-4617. PubMed ID: 28507026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.